tradmap

NHC Financials National Healthcare Corp

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 8.1% per year over the past 5 years.
  • Net income has grown faster than revenue (23.4% vs 8.1% per year).
  • Operating margin has expanded, at 8.5% in the latest year.
  • Free cash flow has declined 3.9% per year over the past 5 years.

Financial health

  • The company holds more cash ($93M) than total debt ($40M).
  • Operating income covered interest expense 20× in the latest year.
  • Total debt is 0.2× EBITDA.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 32.2% of earnings and 26.0% of free cash flow.
  • The dividend has grown 3.9% per year over the past 5 years.
Revenue & net income
$0 $759M $2B 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
0% 6% 13% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Free cash flow (CFO − capex)
-$21M $80M $181M $0 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $74M $147M 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$237M -$17M $203M $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $1.5B $120M 0.0% 8.5% $149M $40M $93M
2024 $1.3B $102M 0.0% 6.9% $80M $137M $76M
2023 $1.1B $67M 0.0% 5.0% $83M $0 $107M
2022 $1.1B $22M 0.0% 2.9% -$21M — $59M
2021 $1.1B $139M 0.0% 4.7% $23M — $108M
2020 $1.0B $42M 0.0% 4.7% $181M — $147M
2019 $996M $68M 0.0% 4.9% $74M $10M $50M
2018 $980M $59M 0.0% 5.7% $69M $55M $43M
2017 $964M $56M 0.0% 5.6% $62M $100M $59M
2016 $924M $51M 0.0% 6.6% $28M $120M $26M
2015 — $53M — — $25M $120M $38M
2014 — $53M — — $22M $10M $70M
2013 — $65M — — $59M $10M $82M
2012 — $59M — — $42M $10M $67M
2011 — $65M — — $59M $10M $61M

Valuation over time

How the market has priced NHC against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 32.2 64.4 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 1.0 2.1 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 1.9 3.8 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is NHC growing its revenue and profit?

Over the past 5 years, National Healthcare Corp's revenue has grown 8.1% per year, and net income grown 23.4% per year. These are computed facts, not advice.

How much debt does NHC have?

As of FY2025, National Healthcare Corp reported $40M of total debt against $93M of cash; operating income covered interest expense 20×.

What is NHC's profit margin?

In FY2025, gross margin was —, operating margin 8.5%, and net margin 7.9%.

What is NHC's P/E ratio?

As of Jun '26, National Healthcare Corp traded at a price-to-earnings ratio of about 26.3× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.